Tag Archives: Alabama
The Alabama Department of Public Health recently filed a “Notice of Intended Action” to amend Alabama’s current Controlled Substance List by rescheduling seven substances to a higher schedule due to the potentials of abuse as recommended by the Alabama Board of Medical Examiners.
The seven substances the Alabama Department of Public Health proposes to reclassify are:
1. Alprazolam – Reschedule from Schedule IV to Schedule II,
2. All other benzodiazepines (Clonazepam, Diazepam, Lorazepam, and Temazepam) from Schedule IV to Schedule III,
3. Pregabalin – Reschedule from Schedule V to Schedule IV,
4. Zolpidem – Reschedule from Schedule IV to Schedule III
The comment period ended on January 4, 2017, and Baer Law will keep you informed on when there is a final ruling as health care providers, pharmacists, pharmacies and wholesalers will have to change their practices to address such changes, especially if alprazolam is reclassified to Schedule II.